Bruker Corporation (BRKR) |
|
74.33 -0.52 (-0.69%)
|
03-24 11:23 |
|
Open: |
74.36 |
Pre. Close: |
74.85 |
|
High:
|
74.91 |
Low:
|
73.37 |
|
Volume:
|
68,584 |
Market Cap:
|
10,907(M) |
|
|
|
Technical analysis |
as of: 2023-03-24 10:42:12 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 89.55 One year: 104.6 |
| Support: |
Support1: 70.19 Support2: 66.19 |
| Resistance: |
Resistance1: 76.67 Resistance2: 89.55 |
| Pivot: |
73.63  |
| Moving Average: |
MA(5): 74.1  MA(20): 72.96
MA(100): 69.44 MA(250): 63.87 |
| MACD: |
MACD(12,26): 0.6 Signal(9): 0.5 |
| Stochastic oscillator: |
%K(14,3): 72.5 %D(3): 74.3 |
| RSI: |
RSI(14): 56.6 |
| 52-week: |
High: 76.8 Low: 48.41 |
| Average Vol(K): |
3-Month: 680 (K) 10-Days: 718 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BRKR ] has closed below upper band by 20.8%. Bollinger Bands are 47.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
76.68 - 76.95 |
76.95 - 77.19 |
|
Low:
|
73.61 - 73.96 |
73.96 - 74.27 |
|
Close:
|
74.31 - 74.79 |
74.79 - 75.22 |
|
Company Description |
|
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts. |
Headline News |
Wed, 22 Mar 2023
One Bruker Corporation (NASDAQ:BRKR) insider upped their stake by 0.004% in the previous year - Simply Wall St
Wed, 22 Mar 2023
Here's one for the battered bulls: the second-largest sector in the ... - Morningstar
Mon, 20 Mar 2023
Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK - Nasdaq
Sun, 19 Mar 2023
Guru Fundamental Report for BRKR - Nasdaq
Sat, 11 Mar 2023
Public Employees Retirement Association of Colorado Increases ... - MarketBeat
Tue, 07 Mar 2023
Bruker (NASDAQ:BRKR) stock performs better than its underlying earnings growth over last five years - Simply Wall St
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
147 (M) |
| Shares Float |
98 (M) |
|
% Held by Insiders
|
32.8 (%) |
|
% Held by Institutions
|
71.8 (%) |
|
Shares Short
|
3,490 (K) |
|
Shares Short P.Month
|
2,950 (K) |
Stock Financials |
|
EPS
|
1.97 |
|
EPS Est Next Qtl
|
0.43 |
|
EPS Est This Year
|
1.12 |
|
EPS Est Next Year
|
1.25 |
|
Book Value (p.s.)
|
7.57 |
|
Profit Margin (%)
|
11.7 |
|
Operating Margin (%)
|
18 |
|
Return on Assets (ttm)
|
7.8 |
|
Return on Equity (ttm)
|
26.9 |
|
Qtrly Rev. Growth
|
3.5 |
|
Gross Profit (p.s.)
|
8.92 |
|
Sales Per Share
|
17.24 |
|
EBITDA (p.s.)
|
3.71 |
|
Qtrly Earnings Growth
|
35 |
|
Operating Cash Flow
|
274 (M) |
|
Levered Free Cash Flow
|
184 (M) |
Stock Valuations |
|
PE Ratio
|
37.96 |
|
PEG Ratio
|
1.5 |
|
Price to Book value
|
9.86 |
|
Price to Sales
|
4.33 |
|
Price to Cash Flow
|
39.99 |
Stock Dividends |
|
Dividend
|
0.05 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2021-12-16 |
|
Ex-Dividend Date
|
2021-11-29 |
|
Your Ad Here
|
|
